Assess safety and device performance of the Medtronic HGMS in the critically-ill setting and analyze the following:~Device Performance:~Functionality of HGMS~Alerts/Alarms Specificity and Sensitivity~System Workflow~Safety:~Descriptive statistics will be used to characterize safety events~Moderate and severe anticipated device and procedure related adverse events~All serious adverse events and unanticipated adverse device effects related events
The purpose of this study is to assess safety and device performance of the Medtronic Hospital Glucose Management System (HGMS) for up to 72-hours.